Inventor · disambiguated record
Kevin C. Glenn
Also filed as: GLENN KEVIN · GLENN KEVIN C · GLENN KEVIN CHALLON
18 granted patents·17 pending applications·447 citations·filing 1986–2007
95Inventor score
Top patents by PatentIndex Score
35 records- 0196US6943189B2Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG CO-A reductase inhibitorsSEARLE & CO·Filed 2003·Granted Sep 13, 2005·78 cites·40 claims
- 0293US5352664AThrombin derived polypeptides; compositions and methods for useUNIV TEXAS·Filed 1986·Granted Oct 4, 1994·55 cites·6 claims
- 0391US6420417B1Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitorsSEARLE & CO·Filed 2000·Granted Jul 16, 2002·37 cites·50 claims
- 0488US5500412AThrombin derived polypeptides; compositions and methods for useFiled 1993·Granted Mar 19, 1996·58 cites·6 claims
- 0587US6642268B2Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitorsSEARLE & CO·Filed 2002·Granted Nov 4, 2003·22 cites·18 claims
- 0682US6794396B2Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 2003·Granted Sep 21, 2004·13 cites·14 claims
- 0780US6630572B1Thrombin derived polypeptides: compositions and methods for useUNIV TEXAS·Filed 2000·Granted Oct 7, 2003·6 cites·16 claims
- 0878US6562860B1Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indicationsSEARLE & CO·Filed 1999·Granted May 13, 2003·39 cites·11 claims
- 0977US6458851B1Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indicationsSEARLE LLC·Filed 1999·Granted Oct 1, 2002·35 cites·8 claims
- 1072US6268392B1Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitorsSEARLE & CO·Filed 1998·Granted Jul 31, 2001·37 cites·49 claims
- 1168US2007203246A1Combinations of Cholesterol Ester Transfer Protein Inhibitors and HMG COA Reductase Inhibitors for Cardiovascular IndicationsPFIZER·Filed 2007·Application pending·0 cites
- 1264US6605624B1Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activityPHARMACIA CORP·Filed 1999·Granted Aug 12, 2003·23 cites·21 claims
- 1364US6462091B1Combinations of cholesteryl ester transfer protein inhibitors and HMG coA reductase inhibitors for cardiovascular indicationsSEARLE & CO·Filed 1999·Granted Oct 8, 2002·15 cites·11 claims
- 1463US6890958B2Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 2002·Granted May 10, 2005·1 cites·9 claims
- 1562US2004220231A1Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activityFiled 2004·Application pending·0 cites
- 1659US6627731B1Thrombin derived polypeptides; compositions and methods for usePHARMACIA CORP·Filed 1995·Granted Sep 30, 2003·11 cites·22 claims
- 1759US2004110761A1Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disordersSEARLE LLC·Filed 2003·Application pending·0 cites
- 1859US2003166712A1Combinations of cholesteryl ester transfer protein inhibitors and HMG CoA reductase inhibitors for cardiovascular indicationsSEARLE & CO·Filed 2002·Application pending·0 cites
- 1952US2002061888A1Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disordersFiled 2001·Application pending·0 cites
- 2050US2004028644A1Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indicationsSEARLE LLC·Filed 2003·Application pending·0 cites
- 2149US2004048846A1Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 2003·Application pending·0 cites
- 2248US6489366B1Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 1999·Granted Dec 3, 2002·6 cites·7 claims
- 2348US6458850B1Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 1999·Granted Oct 1, 2002·6 cites·12 claims
- 2448US2003166720A1Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 2002·Application pending·0 cites
- 2548US2004029845A1Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indicationsSEARLE & CO·Filed 2003·Application pending·0 cites
- 2647US2003203892A1Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indicationsSEARLE LLC·Filed 2002·Application pending·0 cites
- 2746US2003232834A1Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disordersFiled 2001·Application pending·0 cites
- 2844US6569905B1Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indicationsSEARLE LLC·Filed 1999·Granted May 27, 2003·4 cites·10 claims
- 2942US2003118584A1Restoration of platelet aggregation by antibody administration after GPIIB/IIIa antagonist treatmentSEARLE & CO·Filed 2002·Application pending·0 cites
- 3042US2003125316A1Combinations of lleal bile acid transport inhibitors and nicotinic acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 2002·Application pending·0 cites
- 3134US6638969B1Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 1999·Granted Oct 28, 2003·1 cites·13 claims
- 3228US2003100520A1Immunological process and constructs for increasing the hdl cholesterol concentration by dna vaccinationFiled 1999·Application pending·0 cites
- 3327US2003021804A1Immunological process for increasing the hdl cholestrol concentrationFiled 1997·Application pending·0 cites
- 3425US2003026808A1An IMMUNOLOGICAL PROCESS FOR INCREASING THE HDL CHOLESTROL CONCENTRATIONFiled 1999·Application pending·0 cites
- 3519US2002177172A1Restoration of platelet aggregation by antibody administration after gpiib/iiia antagonist treatmentFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kevin C. Glenn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →